FdaApplication
ANDA 219332
Identifiers
- fda_app_no: ANDA219332
Properties
| Property | Value |
|---|---|
| applicant_name | ASCENT PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2025-05-14 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIVAROXABAN | RIVAROXABAN | 15MG | TABLET;ORAL |
| RIVAROXABAN | RIVAROXABAN | 20MG | TABLET;ORAL |
| RIVAROXABAN | RIVAROXABAN | 2.5MG | TABLET;ORAL |
| RIVAROXABAN | RIVAROXABAN | 10MG | TABLET;ORAL |
4 products